Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.
Journal: American journal of hematology
Published: October 06, 2021
Improvements in Health-related Quality of Life and Symptoms in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Final Results From the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 20, 2021
Phase 2, multicenter GIBB study of obinutuzumab plus bendamustine in previously untreated patients with chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma
Published: November 27, 2020
Iron deficiency anemia from iron malabsorption caused by proton pump inhibitors.
Journal: EJHaem
Published: July 28, 2020
Reflections on 45 years as a clinical hematologist.
Journal: Clinical advances in hematology & oncology : H&O
Published: July 02, 2020
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia.
Journal: British journal of haematology
Published: April 04, 2020
Etiologies of Thrombocytopenia in the Community Hospital: The Experience of 1 Hematologist.
Journal: The American journal of medicine
Published: September 29, 2019
Collateral Damages by Magic Bullets: Hemolytic Uremic and Capillary Leak Syndromes After Moxetumomab Pasudotox Therapy.
Journal: The American journal of medicine
Published: May 12, 2019
Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program.
Journal: American journal of hematology
Published: November 25, 2018
Comprehensively understanding fatigue in patients with myeloproliferative neoplasms.
Journal: Cancer
Published: July 07, 2015
Last Updated: 09/26/2026